Home » Practice Areas » Pharmaceutical Liability » VIOXX® Litigation at The Lanier Law Firm
Recent News





Categories
VIOXX® Litigation at The Lanier Law Firm
VIOXX Lawsuit
The Lanier Law Firm is proud of its representation of patients injured by VIOXX®, the controversial pain medication manufactured by Merck & Co. Inc.
Our firm played a significant role in the litigation leading up to the $4.85 billion nationwide settlement with Merck that was announced in late 2007. That settlement is intended to resolve at least 85% of the personal injury VIOXX® lawsuits in the U.S. We remain steadfast in our representation of our clients throughout the settlement process.
The Lanier Law Firm has been a national leader in VIOXX® litigation since firm founder Mark Lanier obtained a $253 million verdict in the country’s first VIOXX® lawsuit in August 2005. That case – decided in favor of the wife of a former marathon runner who died after taking VIOXX® for only eight months – stands as the largest VIOXX® verdict in history.
The Lanier Law Firm also obtained the first-ever VIOXX® consumer fraud findings against Merck. In 2007, a New Jersey Superior Court ruling upheld earlier jury verdicts that found Merck committed consumer fraud by deceiving doctors about the drug’s cardiovascular risks and deliberately hiding information about those risks.